WebsiteClosers® presents a Proprietary Biomedical Tech Business helping clients worldwide take a data-driven approach to longevity and preventive health. This brand has built a single software platform that reads across genetics, epigenetics, immunology, metabolism, neurology, biomedical imaging, and blood lab results to give each client a full picture of their biological health. Every client pays $45,000 per year, and the subscriber base has grown steadily with zero marketing spend.
Business Model
The business runs on a 100% annual subscription model, billing each client once a year on a one-year term. The subscription gives clients full access to the platform, where they can track key health indicators, follow changes over time, and receive personalized insights. The software sends email alerts when it spots a significant potential concern, and each assessment is based on measurable lab results rather than generalized scores. There is no inventory, no seasonality, and no working capital needed. Year-round demand is backed by a 2026 survey showing 34% of U.S. consumers had done voluntary lab testing in the past three years. A new owner is free to keep the current billing structure or add monthly plans.
Digital Marketing & Traffic
Customer acquisition cost sits at $0, as every subscriber has come through professional networking and referrals. The website is already SEO-optimized and draws over 10,000 visitors per month with no blog, paid ads, or social media program in place. Given the $45,000 price point, the seller recommends targeted lead generation, direct outreach, and relationship-based sales over mass-market advertising. A technology demonstration video is already available to support sales conversations.
Operations
The business runs without employees, contractors, or a physical location. The software handles core functions without the founder or a consultant. The owner spends about one hour per client per month on consultations and handles customer support directly. The founder personally built the full system, including the public landing page, the private client interface, and the admin and consultant interface. No special technical skills are needed, and security, compliance, and contingency systems are in place. The full transfer of assets can be completed online in 2 to 3 days.
Business Broker Takeaways
1. Proprietary Technology. The platform reads across seven biological systems in one place, while most competitors cover only one or two. A buyer gets a fully built product instead of developing comparable technology from scratch.
2. Strong Revenue Base. With $45,000 annual subscriptions, a $0 acquisition cost, steady subscriber growth, and no working capital needs, the business is profitable and ready to scale.
3. Founder-Independent Operations. The owner has no issue signing a non-compete. The software runs without daily owner input, and consultations can move to hourly consultants.
Growth Opportunities
A buyer can scale this longevity platform in several directions. B2B licensing on monthly or annual fees could open new recurring revenue from longevity clinics, preventive healthcare providers, insurance companies, and corporate wellness programs. International expansion into the U.S., U.K., UAE, and other high-income markets across the Middle East and Europe requires no physical buildout. Premium tiers, international SEO, a blog, and a social media presence would all bring in new leads. The market supports this push, with the U.S. longevity market projected to grow from $25.2 billion in 2024 to $61.5 billion by 2034, and U.S. personalized medicine expected to climb from $66.13 billion in 2025 to about $253 billion by 2034.
Summary
This acquisition gives a buyer a premium, subscription-based biomedical software business with low overhead, minimal owner time, and untapped marketing and licensing channels. With proprietary technology, a worldwide client base, and a growing market for personalized health monitoring, the business is well positioned for growth under new ownership.
